• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 90 of 100
Parkinson’s patients show improvement after taking cancer drug
HealthParkinson’s patients show improvement after taking cancer drug
By Claire ZillmanOctober 19, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
HealthValeant eases up on strategy to buy up ‘mispriced drugs’
By Laura LorenzettiOctober 19, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
HealthValeant beat expectations in 3Q thanks to U.S. skin business
By Reuters and Fortune EditorsOctober 19, 2015
Hillary Clinton in the first Democratic presidential debate in Las Vegas on Oct. 13
CommentaryClinton’s big pharma takedown plan has some serious issues
By Chris Ford and Bethany CiancioloOctober 16, 2015
Democratic Candidates Attend New Hampshire Democratic Party Convention
LeadershipBernie Sanders rejects drug price-raising CEO’s donation: ‘We don’t want his stinkin’ money’
By Michal AddadyOctober 16, 2015
CNBC NEWS-- Pictured: Jeb Bush, former Governor of Florida and 2016 presidential election candidate, in an interview at the Parlor City Pub and Eatery in Cedar Rapids, Iowa on September 22, 2015 -- (Photo by: Mary Stevens/CNBC/NBCU Photo Bank)
HealthJeb Bush’s health care plan would dismantle Obamacare
By Laura LorenzettiOctober 15, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
HealthValeant under federal investigation for how it prices drugs
By Laura LorenzettiOctober 15, 2015
Johnson & Johnson Products Ahead Of Earnings
HealthJohnson & Johnson struggles to boost drug sales even as profits gain
By Laura LorenzettiOctober 13, 2015
Eli Lilly & Co's Zyprexa schizophrenia drug is pictured in a
FinanceEli Lilly adds one more to roster of failed heart drugs, and it won’t be the last
By Laura LorenzettiOctober 12, 2015
General Views of Eli Lilly & Co.
HealthWhy drug maker Eli Lilly’s stock price is down big today
By John KellOctober 12, 2015
Hedge fund manager Bill Ackman
FinanceThe strange thing about Bill Ackman’s defense of Valeant’s drug prices
By Stephen GandelOctober 7, 2015
AmerisourceBergen pays $2.58 billion to buy PharMEDium
HealthAmerisourceBergen pays $2.58 billion to buy PharMEDium
By Laura LorenzettiOctober 6, 2015
Symbolic - biotechnology - genetic engineering
HealthTPP trade deal: Even more bad news for biotech industry
By Laura LorenzettiOctober 5, 2015
Japan Scenics
HealthThis Japanese pufferfish could be the ultimate painkiller
By Laura LorenzettiSeptember 30, 2015
Why drug price controversy is great news for this hedge fund manager
FinanceWhy drug price controversy is great news for this hedge fund manager
By Jen WiecznerSeptember 30, 2015
1...
  • 88
  • 89
  • 90
  • 91
  • 92
...100
Most Popular
Success
Anne Hathaway says she was spammed with ChatGPT-written thank you notes after hiring for a recent role: ‘Nobody on that list gets that job’placeholder alt text
By Orianna Rosa RoyleJune 18, 2026
Economy
The affordability crisis is so bad that, for the first time ever, both mom and dad are working full-time in most American familiesplaceholder alt text
By Jacqueline MunisJune 17, 2026
Personal Finance
Current price of oil as of June 17, 2026placeholder alt text
By Joseph HostetlerJune 17, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.